SE403380B - Forfarande for framstellning av 17alfa-estrar-21-halogenpregnaner - Google Patents

Forfarande for framstellning av 17alfa-estrar-21-halogenpregnaner

Info

Publication number
SE403380B
SE403380B SE7603791A SE7603791A SE403380B SE 403380 B SE403380 B SE 403380B SE 7603791 A SE7603791 A SE 7603791A SE 7603791 A SE7603791 A SE 7603791A SE 403380 B SE403380 B SE 403380B
Authority
SE
Sweden
Prior art keywords
pregnants
17alfa
estrar
halogen
preparing
Prior art date
Application number
SE7603791A
Other languages
English (en)
Swedish (sv)
Other versions
SE7603791L (sv
Inventor
Y Kamano
K Michishita
T Seki
I Tanaka
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50038914A external-priority patent/JPS51125372A/ja
Priority claimed from JP50052085A external-priority patent/JPS51128954A/ja
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of SE7603791L publication Critical patent/SE7603791L/xx
Publication of SE403380B publication Critical patent/SE403380B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7603791A 1975-03-31 1976-03-30 Forfarande for framstellning av 17alfa-estrar-21-halogenpregnaner SE403380B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP50038914A JPS51125372A (en) 1975-03-31 1975-03-31 Aprocess for preparing pregnane steroid-17-ester-21-halides
JP50052085A JPS51128954A (en) 1975-05-01 1975-05-01 Process for preparing 17-ester-21-halides of pregnate type s teroids

Publications (2)

Publication Number Publication Date
SE7603791L SE7603791L (sv) 1976-10-01
SE403380B true SE403380B (sv) 1978-08-14

Family

ID=26378215

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7603791A SE403380B (sv) 1975-03-31 1976-03-30 Forfarande for framstellning av 17alfa-estrar-21-halogenpregnaner

Country Status (14)

Country Link
US (1) US4113680A (xx)
CA (1) CA1044225A (xx)
CH (1) CH609709A5 (xx)
DE (1) DE2613875A1 (xx)
DK (1) DK141171B (xx)
ES (1) ES446411A1 (xx)
FR (1) FR2306214A1 (xx)
GB (1) GB1508517A (xx)
HU (1) HU174850B (xx)
IN (1) IN142583B (xx)
NL (1) NL7603249A (xx)
PT (1) PT64885B (xx)
SE (1) SE403380B (xx)
YU (1) YU54476A (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2742982C2 (de) * 1977-09-21 1985-12-12 Schering AG, 1000 Berlin und 4709 Bergkamen 9-Chlorprednisolon-Derivate, Verfahren zu deren Herstellung und diese enthaltendes pharmazeutisches Präparat
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
US4361558A (en) * 1980-04-29 1982-11-30 Ciba-Geigy Corporation Halogenated steroids
US4440689A (en) * 1981-07-22 1984-04-03 Mitsubishi Chemical Industries, Limited Acyloxysteroids and process for producing same
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
DE3915951C1 (xx) * 1989-05-12 1990-09-13 Schering Ag, 1000 Berlin Und 4709 Bergkamen, De
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
DK1305329T4 (da) * 2000-08-05 2015-06-15 Glaxo Group Ltd 6alpha, 9alpha-difluor-17alpha-(2-furanylcarboxyl)oxy-11beta-hydroxy-16alpha-methyl-3-oxo-androst-1,4-dien-17-carbothiosyre-S-fluormethylester som et antiinflammatorisk middel
PL366937A1 (en) * 2001-04-30 2005-02-07 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
AU2002356759A1 (en) * 2001-12-01 2003-06-17 Glaxo Group Limited 17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US7208485B2 (en) * 2003-01-13 2007-04-24 Chemagis Ltd. Crystalline forms of halobetasol propionate
US20040138192A1 (en) * 2003-01-13 2004-07-15 Chemagis Ltd. Crystalline forms of halobetasol propionate
AT501376B1 (de) * 2005-01-17 2010-11-15 Pregenzer Bruno Glucokortikoid-hältiges arzneimittel
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
CN109608511B (zh) * 2019-01-24 2021-05-04 上海新华联制药有限公司 泼尼松龙醋酸戊酸酯的化学合成工艺

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE373332C (sv) * 1972-02-25 1977-07-25 Centralsug Ab Anordning for utvinning av fibermaterial ur blandat gods
US3992422A (en) * 1975-08-14 1976-11-16 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes

Also Published As

Publication number Publication date
CH609709A5 (xx) 1979-03-15
YU54476A (en) 1982-05-31
US4113680A (en) 1978-09-12
IN142583B (xx) 1977-07-30
FR2306214B1 (xx) 1981-04-30
ES446411A1 (es) 1979-02-01
DK141171C (xx) 1980-07-07
GB1508517A (en) 1978-04-26
NL7603249A (nl) 1976-10-04
DK144076A (xx) 1976-10-01
SE7603791L (sv) 1976-10-01
PT64885A (en) 1976-04-01
CA1044225A (en) 1978-12-12
FR2306214A1 (fr) 1976-10-29
PT64885B (en) 1977-11-17
DE2613875A1 (de) 1976-10-14
DK141171B (da) 1980-01-28
HU174850B (hu) 1980-03-28

Similar Documents

Publication Publication Date Title
SE429970B (sv) Forfarande for framstellning av glukopyranosido-1,6-mannit
SE442295B (sv) Forfarande for framstellning av 4-amino-5-en-hexansyra
SE431456B (sv) Analogiforfarande for framstellning av kondenserade kinazolonderivat
SE434394B (sv) Analogiforfarande for framstellning av kinolonalkansyraderivat
SE403380B (sv) Forfarande for framstellning av 17alfa-estrar-21-halogenpregnaner
SE431089B (sv) Forfarande for framstellning av beta-metyltio-propionaldehyd
NO773548L (no) Fremgangsmaate for fremstilling av spiro-hydantoinderivater
SE412817B (sv) Halogenglodlampa
IT1055449B (it) Politioli contenenti alogeni
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
SE426595B (sv) Forfarande for framstellning av cellulosaetrar
SE7613973L (sv) Forfarande for framstellning av pappersmassa
SE7613768L (sv) Forfarande for framstellning av penicillinestrar
SE431871B (sv) Forfarande for framstellning av 2-brom-6-fluor-n-2-imidazolidinylidenbensamin
SE428296B (sv) Analogiforfarande for framstellning av substituerade difonylsulfider
SE423390B (sv) Foerfarande foer framstaellning av eburnameninderivat
SE423025B (sv) Forfarande for framstellning av proteinfilameter
SE422205B (sv) Forfarande for framstellning av 1-karbamoyl-5-fluoruracil derivat
SE423902B (sv) Forfarande for framstellning av purinderivat
NO147672C (no) Analogifremgangsmaate for fremstilling av n-aryl-n-(1-l1-4-piperidinyl)-arylacetamider
SE7606890L (sv) Forfarande for framstellning av polyacetovinyldispersioner
SE421125B (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
SE420093B (sv) Forfarande for framstellning av 5-fenyl-2-furamidoximer
SE418287B (sv) Forfarande for framstellning av guajakol-p-isobutyl-hydratropat
IT1068946B (it) Procedimento per prepararae triemtilidrochinone